Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
2008-6-13
pubmed:abstractText
This study evaluated whether a xanthine oxidase (XO) inhibitor, oxypurinol, produces clinical benefits in patients with New York Heart Association functional class III to IV heart failure due to systolic dysfunction receiving optimal medical therapy.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1558-3597
pubmed:author
pubmed:issnType
Electronic
pubmed:day
17
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2301-9
pubmed:dateRevised
2009-6-24
pubmed:meshHeading
pubmed-meshheading:18549913-Adolescent, pubmed-meshheading:18549913-Adult, pubmed-meshheading:18549913-Aged, pubmed-meshheading:18549913-Aged, 80 and over, pubmed-meshheading:18549913-Double-Blind Method, pubmed-meshheading:18549913-Enzyme Inhibitors, pubmed-meshheading:18549913-Female, pubmed-meshheading:18549913-Health Status Indicators, pubmed-meshheading:18549913-Heart Failure, pubmed-meshheading:18549913-Humans, pubmed-meshheading:18549913-Male, pubmed-meshheading:18549913-Middle Aged, pubmed-meshheading:18549913-Natriuretic Peptide, Brain, pubmed-meshheading:18549913-Oxypurinol, pubmed-meshheading:18549913-Quality of Life, pubmed-meshheading:18549913-Questionnaires, pubmed-meshheading:18549913-Systole, pubmed-meshheading:18549913-Uric Acid, pubmed-meshheading:18549913-Xanthine Oxidase
pubmed:year
2008
pubmed:articleTitle
Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study.
pubmed:affiliation
The University of Miami Miller School of Medicine, Miami, Florida v, USA. jhare@med.miami.edu
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Multicenter Study